NVOCANA

Welcome to the Brand page for “NVOCANA”, which is offered here for Human pharmaceuticals for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, metabolic diseases, anti-viral diseases, oncologic diseases, respiratory diseases, ophthalmic diseases and gastro-intestinal diseases;.

Its status is currently believed to be active. Its class is unavailable. “NVOCANA” is believed to be currently owned by “Johnson & Johnson”.


Owner:
JOHNSON & JOHNSON
Owner Details
Description:
Human pharmaceuticals for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, metabolic diseases, anti-viral diseases, oncologic diseases, respiratory diseases, ophthalmic diseases and gastro-intestinal diseases;
Categories: HUMAN PHARMACEUTICALS TREATMENT